- Home
- ESP vs HURA Comparison
ESP vs HURA Comparison
Compare ESP & HURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ESP | HURA |
|---|---|---|
| Founded | 1928 | 2009 |
| Country | United States | United States |
| Employees | N/A | 22 |
| Industry | Industrial Machinery/Components | |
| Sector | Technology | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 165.6M | 160.5M |
| IPO Year | 1995 | N/A |
Fundamental Metrics
Financial Performance| Metric | ESP | HURA |
|---|---|---|
| Price | $58.04 | $2.25 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $64.00 | $9.50 |
| AVG Volume (30 Days) | 52.8K | ★ 731.4K |
| Earning Date | 05-13-2026 | 05-15-2026 |
| Dividend Yield | ★ 1.50% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 2.74 | N/A |
| Revenue | ★ $43,950,872.00 | N/A |
| Revenue This Year | $10.30 | N/A |
| Revenue Next Year | $10.00 | N/A |
| P/E Ratio | $21.43 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $36.00 | $0.41 |
| 52 Week High | $74.77 | $3.90 |
Technical Indicators
Market Signals| Indicator | ESP | HURA |
|---|---|---|
| Relative Strength Index (RSI) | 45.06 | 47.35 |
| Support Level | $54.00 | $2.14 |
| Resistance Level | $61.58 | $2.60 |
| Average True Range (ATR) | 3.03 | 0.16 |
| MACD | -0.39 | -0.02 |
| Stochastic Oscillator | 23.35 | 24.44 |
Price Performance
Historical ComparisonAbout ESP Espey Mfg. & Electronics Corp.
Espey Manufacturing & Electronics Corp is a power electronics design and OEM manufacturing company delivering products for military and severe environment applications. Its products include power supplies, power converters, filters, power transformers, magnetic components, power distribution equipment, UPS systems, and antennas. The applications of these products include AC and DC locomotives, shipboard power, shipboard radar, airborne power, ground-based radar, and ground mobile power. Espey services include design and development to specification, build to specifications provided by the customer, build to print, design services, design studies, environmental testing services, metal fabrication, painting services, and development of automatic testing equipment.
About HURA TuHURA Biosciences Inc.
TuHURA Biosciences Inc is a phase 3 clinical stage immuno-oncology company with three distinct technologies focused on the development of novel therapeutics designed to overcome primary and acquired resistance to cancer immunotherapies. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. The company operates in one reportable segment, which includes all activities related to advancing therapies for cancer treatment.